Biologics represented 5% of the drugs prescribed in the U.S. in 2024, but they accounted for more than half of the country’s total prescription medicine spending, according to health data analysis ...

The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...

Two manufacturers have issued recalls for generic Adderall, one over unknown impurities and the other over bottle mislabeling ...

Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.

Tatenda Makoni is a Zimbabwean-born medical student at the Medical College of Wisconsin whose work bridges global health and ...

America's drug supply faces a serious threat from China's increasing control. A US commission warns that a quarter of generic ...

In the past, biosimilar makers have been able to invalidate some of those patents through a sped-up process called “inter ...

The Food and Drug Administration has approved the first generic version of Premarin (conjugated estrogens) tablets.

See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

Eli Lilly and Novo Nordisk have agreed to sell their weight loss drugs, Wegovy and Zepbound, through the new TrumpRx ...

Patent reforms could address a problem that’s been driving rising prescription drug costs and create a more competitive ...